Leading CLA researchers and suppliers have slammed product claims that safflower oil is superior to CLA (conjugated linoleic acid) for reducing 'belly' fat, as the CLA community unites to set the record straight on the science.
Long-term intakes of conjugated linoleic acid (CLA) may be associated with bone strength in men, says a new study from Canada and Australia, but the conclusions have been questioned by a leading CLA supplier.
Conjugated linoleic acid (CLA) is safe for use in foods at doses of 3-3.5g per day, the European Food Safety Authority (EFSA) has affirmed in an opinion broadly welcomed by a key player even if novel foods approval remains elusive.
Probiotic bacteria strains tailored to express produce conjugated linoleic acid (CLA) may be able to modify fat tissues, and could play a role in the prevention and treatment of obesity, according to new research in mice.
Fat reduction ingredient conjugated linoleic acid (CLA) is one step closer to novel food approval in Europe, after the European Food Safety Authority (EFSA) gave its stamp of approval for the ingredient’s safety.
In response to a recent BMJ editorial claiming that only drugs are effective for weight loss, members of the global food and supplements industries have defended the efficacy of their products, calling the article the “latest misinformed campaign”.
Following the juxtaposition of two CLA (conjugated linoleic acid)
studies in a communiqué from Ohio State University, Cognis and the
lead author have spoken out to clarify what they say is a
misrepresentation of the results.
Two Ohio State University studies involving CLA fed to mice and
rats are reported to have brought about diverging results that
suggest opposing potential effects in humans. However, it is
generally accepted that humans react physiologically...
Supplementation with conjugated linoleic acid (CLA) prevented
age-related bone loss in mice, says a new study that could offer a
dietary therapy for protecting against the ever-growing threat of
Supplementation with conjugated linoleic acid (CLA) could prevent
weight and fat gain at times of the year when people are most
susceptible, as well as during the natural ageing process, says a
new study supported by Cognis.
Lipid Nutrition is today announcing the findings of a new human
trial using CLA, that reinforces the fatty acid's fat mass
reduction claim and shed light on the main locations of the fat
reduction on the human body.
PharmaNutrients has added another patent to its intellectual
property store, on the use of CLA One to prevent or minimize the
onset of stress catabolic response in patients who have undergone
surgery or suffer from auto-immune disorders...
A report recommending measures to reduce trans fat consumption in
France raises questions about the safety of conjugated linoleic
acid (CLA), currently being marketed for its weight loss benefits,
and also considered a trans fat...
Supplements of conguated linoleic acid (CLA) taken for two years
helped overweight adults keep their body fat mass down, without
having to restrict calories or change exercise habits, shows a
study published today.
PharmaNutrients has taken further steps to build up its position in
the CLA market by filing the first structure-function claims for
the body composition benefits of its branded CLA (conjugated
linoleic acid) product CLA One.
PharmaNutrients has been granted a new patent for its combination
of CLA (conjugated linoleic acid) with glucosamine and ascorbic
acid, used to address inflammation-related disorders, reports
Cognis' energies at last week's SupplySide West show in Las Vegas -
which closed its doors on Friday - were concentrated on its body
fat reducing product Tonalin, which continues to drive sales in the
Health ingredients firm Cognis launched a new form of CLA suitable
for use in beverages, nutritional bars and dietary supplements, at
last week's Supply Side West show in Las Vegas, reports Philippa
Netherlands-based Lipid Nutrition has introduced a 95 per cent
concentration of its Clarinol brand conjugated linoleic acid (CLA),
said to be the highest form of CLA available to the nutraceutical
Dutch firm Loders Croklaan Lipid Nutrition is the first company to
demonstrate the safety of its conjugated linoleic acid, a fatty
acid hailed as the next big weight loss ingredient, writes
Loders Croklaan specialty fats unit Lipid Nutrition has settled a
patent dispute with Norwegian licensing company Natural, defending
the rights to its manufacturing process for CLA, the leading
product in its portfolio.
The flurry of activity in CLA applications is being backed by a
growing body of research to support the ingredient, particularly
for its effects on weight loss, potentially one of its most
profitable uses in the functional foods market.
A probiotic cheese and products with high CLA levels are among the
foods being developed at a new €16 million functional food research
centre, recently opened in Ireland. One of its goals is to boost
the competitive advantage of Irish...